Life science & clinical diagnostics instruments

Thermo Scientific SOLAµ solid-phase extraction plates

15 May, 2014 | Supplied by: Thermo Fisher Scientific

Thermo Scientific SOLAµ solid-phase extraction (SPE) micro elution plates are designed to deliver robust, reproducible processing at elution volumes as low as 25 µL.


Researchers explore the evolution of enamel

12 May, 2014

Geneticists and evolutionary anthropologists at Duke University have identified two segments of DNA where natural selection may have acted to give modern humans their thick tooth enamel - a feature which distinguishes the genus Homo from our primate relatives and forebears.


Building bone marrow-on-a-chip

09 May, 2014

Researchers from the Wyss Institute have created a new organ-on-a-chip - a microfluidic device that mimics the physiology of a living organism. The device reproduces the structure, functions and cellular make-up of bone marrow.


Fluorescent dye for DNA detection

08 May, 2014

Scientists at the US Department of Energy's Brookhaven National Laboratory have developed a highly sensitive way to detect specific sequences of DNA.


DNA blood test for bowel cancer

06 May, 2014

Australian scientists have presented data on a blood test for bowel cancer which is based on two genes that 'leak' into the blood. Developed between biotechnology company Clinical Genomics and CSIRO, the test was clinically validated in collaboration with the Flinders Centre for Innovation in Cancer at Flinders University.


Still no calcification in regenerative tissue technology

05 May, 2014

Biotechnology company Admedus has revealed that CardioCel, its collagen cardiovascular scaffold used to repair heart defects, has shown no detectable calcification or any other issues in the six years following implantation.


Oxford Gene Technology SureSeq Solid Tumour Panel

01 May, 2014 | Supplied by: Oxford Gene Technology

Oxford Gene Technology (OGT) has launched the SureSeq Solid Tumour Panel. Fully validated on formalin-fixed, paraffin-embedded (FFPE) samples, the 60-gene, next-generation sequencing, hybridisation-based enrichment panel offers researchers solid tumour profiling for both known and novel variants.


'Achilles heel' of tumour cells discovered

30 April, 2014

A study has shown that fast-growing cancer cells are sensitive towards imbalances in the metabolism of nucleotides, the building blocks of DNA - a vulnerability that can be exploited for a novel anti-tumour therapeutic approach.


DiaSorin Liaison Ixt/Arrow CellSep Advanced for automated cell separation

30 April, 2014 | Supplied by: DiaSorin Australia Pty Ltd

DiaSorin has launched Liaison Ixt/Arrow CellSep Advanced for the automated isolation of cells directly from whole blood or buffy coat. Based on magnetic bead technology, the product can isolate up to three cell types per sample in just 32 min per cell type.


GeneCopoeia stable cell line development services

30 April, 2014 | Supplied by: United Bioresearch Products Pty Ltd

GeneCopoeia offers services for establishing stable cell lines for protein overexpression, gene knockdown or genome editing which meet the user's specific research needs.


Successful antibody screening study

28 April, 2014

Therapeutic antibody supplier MorphoSys and technology company Biametrics will continue their collaboration in the area of high-throughput antibody screening following a successful feasibility study.


Stem cells demonstrate rare absorption property

24 April, 2014

Scientists at the University of Cambridge have found that stem cells demonstrate a bizarre property, known as auxeticity, never before seen at a cellular level.


Whooping cough bacterium is evolving

23 April, 2014

Research led by the University of New South Wales (UNSW) has found that the bacterium that causes whooping cough, Bordetella pertussis, has changed - most likely in response to the vaccine used to prevent the disease.


Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs

16 April, 2014 | Supplied by: Millennium Science Pty Ltd

The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNVs) in patients referred for chromosomal testing. It is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.


Hereditary trauma demonstrated in mice

15 April, 2014

Researchers from the University of Zurich and ETH Zurich have discovered a piece in the puzzle which explains how the inheritance of traumas may be mediated.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd